From: Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity
Healthy volunteers | Sepsis | CTS-TXA | Cirrhotic liver disease | Pregnancy | |
---|---|---|---|---|---|
Hb (mmol/L) |
9.0 (8.4–9.6) |
6.0*
(5.6–6.3) |
6.2*
(5.7–6.7) |
7.7*
(7.2–8.4) |
7.8*
(7.0–8.4) |
Ht (L/L) |
0.43 (0.40–0.45) |
0.29*
(0.27–0.31) |
0.29*
(0.26–0.32) |
0.38*
(0.34–0.39) |
0.36*
(0.34–0.39) |
PLT (x109/L) |
178 (139–212) |
141 (95–213) |
101*
(91–140) |
99*
(62–136) |
202 (127–234) |
WBC (x109/L) |
6.4 (5.4–7.9) |
20.1*
(11.5–25.3) |
10.7*
(8.3–12.4) |
5.0 (4.0–7.5) |
10.7*
(9.3–11.7) |
PT (s) |
10.5 (10.2–10.8) |
11.5*
(10.7–12.1) |
11.8*
(11.5–12.4) |
13.3*
(13.0–13.5) |
9.6*
(9.3–9.6) |
aPTT (s) |
27 (26–27) |
33.5*
(30–42.5) |
30*
(28–33) |
29*
(29–34) |
25*
(23–25) |